Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

609 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors

NCT04972981

Conditions
Advanced Solid Tumors
Locations
  • Sarah Cannon at HealthONE Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Emory University, Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
View all 13 locations
View Trial Details
Completed

A Study of the Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid Tumors

NCT02799095

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +34 more
Locations
  • Mural Oncology Investigational Site Denver, Colorado, United States
  • Mural Oncology Investigational Site Port Saint Lucie, Florida, United States
  • Mural Oncology Investigational Site Tampa, Florida, United States
  • Mural Oncology Investigational Site Lexington, Kentucky, United States
View all 31 locations
View Trial Details
Completed

A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

NCT03260322

Conditions
Advanced Solid Tumors, Neoplasms
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of California, Davis Sacramento, California, United States
View all 54 locations
View Trial Details
Completed

A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors

NCT04943900

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +21 more
Locations
  • Local Institution - 0006 Atlanta, Georgia, United States
  • Local Institution - 0005 Baltimore, Maryland, United States
  • Local Institution - 0002 Hackensack, New Jersey, United States
  • Local Institution - 0013 Cleveland, Ohio, United States
View all 19 locations
View Trial Details
Completed

Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)

NCT03179436

Conditions
Advanced Solid Tumors, Parkinson Disease 4, Autosomal Dominant Lewy Body
Locations
  • Banner MD Anderson Cancer Center ( Site 0013) Gilbert, Arizona, United States
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0005) Hackensack, New Jersey, United States
  • Tennessee Oncology Nashville ( Site 0004) Nashville, Tennessee, United States
  • South Texas Accelerated Research Therapeutics, LLC (START) ( Site 0001) San Antonio, Texas, United States
View all 53 locations
View Trial Details
Completed

Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors

NCT04716634

Conditions
Advanced Solid Tumors
Locations
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • The First Hospital of Lanzhou University Lanzhou, Gansu, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
View all 13 locations
View Trial Details
Completed

Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

NCT05775406

Conditions
Acute Lymphocytic Leukemia, Advanced Solid Tumors, Hematologic Diseases, +13 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Henry Ford Health System Detroit, Michigan, United States
View Trial Details
Completed

A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors

NCT01946789

Conditions
Advanced Solid Tumors, Melanoma, Neoplasm Metastasis, +14 more
Locations
  • University of Minnesota Minneapolis, Minnesota, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
View Trial Details

Related conditions